TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 24 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 41,167 | $26,722 | 2.14% |
| SILVERBACK ASSET MANAGEMENT LLC | 12,500,000 | $8,093,188 | 1.11% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 26,500,000 | $17,217,315 | 0.72% |
| BRAIDWELL LP | 28,350,000 | $18,393,480 | 0.58% |
| UBS OCONNOR LLC | 25,000,000 | $16,144,712 | 0.41% |
| WOLVERINE ASSET MANAGEMENT LLC | 45,400,000 | $29,373,729 | 0.33% |
| Lion Point Capital, LP | 1,000,000 | $647,930 | 0.29% |
| Segantii Capital Management Ltd | 7,500,000 | $4,873,085 | 0.17% |
| READYSTATE ASSET MANAGEMENT LP | 3,000,000 | $1,946,400 | 0.10% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 23,393,000 | $15,177,378 | 0.07% |
| AVIVA PLC | 23,000,000 | $14,583,012 | 0.06% |
| D. E. Shaw & Co., Inc. | 40,689,000 | $26,279,495 | 0.03% |
| LAZARD ASSET MANAGEMENT LLC | 24,000,000 | $15,571 | 0.02% |
| CAAS CAPITAL MANAGEMENT LP | 500,000 | $317,022 | 0.02% |
| NOMURA HOLDINGS INC | 479,520 | $4,301,872 | 0.01% |
| LINDEN ADVISORS LP | 1,493,000 | $963,161 | 0.01% |
| CITIGROUP INC | 20,022,000 | $12,890,164 | 0.01% |
| Point72 Asset Management, L.P. | 2,557,000 | $1,655,330 | 0.01% |
| Leucadia National | 500,000 | $322,530 | 0.00% |
| JANE STREET GROUP, LLC | 2,733,000 | $1,764,493 | 0.00% |
This page lists TRAVERE THERAPEUTICS INC's shareholders in Q3 2023. To view TRAVERE THERAPEUTICS INC's shareholder history, click here.